| Protein kinase C(theta) in T cell activation | Annual Review of Immunology | 2002 | 295 |
| Prohibitin co-localizes with Rb in the nucleus and recruits N-CoR and HDAC1 for transcriptional repression | Oncogene | 2002 | 184 |
| Basal levels and patterns of anticancer drug-induced activation of nuclear factor-kappaB (NF-kappaB), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells | Biochemical Pharmacology | 2002 | 143 |
| Haplotype structure of the UDP-glucuronosyltransferase 1A1 promoter in different ethnic groups | Pharmacogenetics and Genomics | 2002 | 142 |
| Cell-surface prion protein interacts with glycosaminoglycans | Biochemical Journal | 2002 | 121 |
| Increase of the resistance of human cervical carcinoma cells to cisplatin by inhibition of the MEK to ERK signaling pathway partly via enhancement of anticancer drug-induced NF kappa B activation | Biochemical Pharmacology | 2002 | 113 |
| Prohibitin requires Brg-1 and Brm for the repression of E2F and cell growth | EMBO Journal | 2002 | 105 |
| Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation | Leukemia | 2002 | 95 |
| Update on pharmacogenetics in cancer chemotherapy | European Journal of Cancer | 2002 | 72 |
| Amplification of wild-type K-ras promotes growth of head and neck squamous cell carcinoma | Cancer Research | 2002 | 60 |
| Heterogeneity of normal prion protein in two- dimensional immunoblot: presence of various glycosylated and truncated forms | Journal of Neurochemistry | 2002 | 58 |
| Identification of autoantibodies associated with systemic lupus erythematosus | Biochemical and Biophysical Research Communications | 2002 | 47 |
| In vitro characterization of hepatic flavopiridol metabolism using human liver microsomes and recombinant UGT enzymes | Pharmaceutical Research | 2002 | 40 |
| Phase I clinical and pharmacokinetic study of protein kinase C-alpha antisense oligonucleotide ISIS 3521 administered in combination with 5-fluorouracil and leucovorin in patients with advanced cancer | Clinical Cancer Research | 2002 | 39 |
| Regulation of Egr-1 by association with the proteasome component C8 | Biochimica Et Biophysica Acta - Molecular Cell Research | 2002 | 32 |
| Increased risk of parvovirus B19 infection in young adult cancer patients receiving multiple courses of chemotherapy | Journal of Clinical Microbiology | 2002 | 28 |
| Prognostic value of multidrug resistance 1, glutathione-S-transferase-pi and p53 in advanced nasopharyngeal carcinoma treated with systemic chemotherapy | Oncology | 2002 | 26 |
| Signaling by the Mpl receptor involves IKK and NF-kappaB | Journal of Cellular Biochemistry | 2002 | 22 |
| Use of Medicare claims data to measure county-level variation in breast carcinoma incidence and mammography rates | Cancer Detection and Prevention | 2002 | 20 |
| Epstein-Barr virus latent membrane protein-1 induction by histone deacetylase inhibitors mediates induction of intercellular adhesion molecule-1 expression and homotypic aggregation | Virology | 2002 | 19 |
| Immunogene therapy of tumors with a vaccine based on the ligand-binding domain of chicken homologous integrin beta3 | Immunological Investigations | 2002 | 19 |
| Carcinogen-induced S-phase arrest is Chk1 mediated and caffeine sensitive | Cell Growth & Differentiation: the Molecular Biology Journal of the American Association for Cancer Research | 2002 | 19 |
| A phase II trial of oral temozolomide in patients with metastatic renal cell cancer | Cancer Chemotherapy and Pharmacology | 2002 | 15 |
| Autoantibody to DNA binding protein B as a novel serologic marker in systemic sclerosis | Biochemical and Biophysical Research Communications | 2002 | 15 |
| p130 mediates TGF-beta-induced cell-cycle arrest in Rb mutant HT-3 cells | Gynecologic Oncology | 2002 | 10 |
